Insider Trading May 28, 2026 09:58 PM

Insider Activity and Earnings Report Detail Key Developments for Myomo Inc.

CMO sells company stock amid positive Q1 results, prompting analysis of valuation and cash burn rates.

By Sofia Navarro MYO

The Chief Medical Officer of MYOMO, INC., Harry Kovelman, recently executed open market sales of the company's common stock totaling $32,239. This insider selling occurred while Myomo Inc. reported stronger-than-expected Q1 2026 earnings, surpassing both revenue and EPS forecasts. The report details the specifics of the stock transactions, the financial performance metrics, and current valuation insights for MYO.

Insider Activity and Earnings Report Detail Key Developments for Myomo Inc.
MYO

Key Points

  • The Q1 2026 earnings report showed Myomo Inc. surpassing both revenue and EPS forecasts, indicating stronger-than-expected quarterly financial performance.
  • Despite the positive financial results, the company's stock price experienced a decline during after-hours trading.
  • Insider selling by CMO Harry Kovelman occurred while the stock maintained a strong three-month return of 22%, though analysts suggest potential undervaluation with a Fair Value of $1.31.

MYOMO, INC. (NASDAQ:MYO) has seen recent activity regarding its insider holdings, as Chief Medical Officer Harry Kovelman recently sold company common stock through open market transactions. The total value of these sales amounted to $32,239.

The transactions took place across two days, May 27 and May 28, 2026. During this period, the selling shares were priced within a narrow range, specifically between $1.002 and $1.0172 per share. On May 27, Kovelman disposed of 20,464 common stock shares, achieving a weighted average price of $1.002 per share. These initial sales were conducted in several lots with individual prices ranging from $1.00 to $1.005.

The subsequent day, May 28, involved the sale of an additional 11,536 common stock shares. The weighted average price for these shares was $1.0172 per share, with transaction lots showing prices that fluctuated between $1.00 and $1.035. Following both sets of sales, Kovelman's direct holding of MYOMO, INC. common stock stands at 108,618 shares.


The timing of this insider sale occurs against a backdrop of recent positive performance metrics for the company. MYO stock is currently trading at $1.09 and has demonstrated a strong return of 22% over the preceding three months. Furthermore, an analysis provided by InvestingPro suggests that the stock may be undervalued at current market levels, assigning it a Fair Value estimate of $1.31.

In terms of company finances, Myomo Inc. released its Q1 2026 earnings report. The results indicated a stronger-than-expected financial performance for the quarter. Specifically, the company reported an Earnings Per Share (EPS) of -$0.07, which outperformed the anticipated figure of -$0.12. Revenue also exceeded projections, reaching $10.1 million compared to a forecasted amount of $9.24 million.

While the earnings report was positive, the development noted in after-hours trading saw a decline in Myomo’s stock price. This fluctuation is an element that may capture the attention of investors monitoring the company's financial health. It should also be noted that the company maintains liquid assets that surpass its short-term obligations. However, specialized insights available to subscribers highlight that the company is rapidly consuming cash—a key point for those assessing balance sheet resilience.


Risks

  • The company is noted to be 'quickly burning through cash,' which raises concerns regarding its balance sheet resilience.
  • Despite the positive earnings report, the stock price declined in after-hours trading, signaling potential investor caution or market reaction.
  • A key operational risk highlighted by analysts is the rapid depletion of liquid assets relative to future needs.

More from Insider Trading

Horizon Kinetics Adds $406 Stake in Texas Pacific Land Corp Amid Stock Surge Jun 4, 2026 RCG Fund Insider Activity: Co-Portfolio Manager Peter Doyle Acquires Additional RCG Shares Jun 4, 2026 FMAO Director Andrew J. Briggs Executes $82K Stock Sale Under Pre-Arranged Plan Jun 4, 2026 Global Innovative Platforms Insider: David Brown Accumulates $202,000 in Stock Jun 4, 2026 Itron SVP John Marcolini Executes $946,085 Share Sale Under Pre-Arranged Plan Jun 4, 2026